These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3807961)

  • 1. Early deposition of aluminum in bone in diabetic patients on hemodialysis.
    Andress DL; Kopp JB; Maloney NA; Coburn JW; Sherrard DJ
    N Engl J Med; 1987 Feb; 316(6):292-6. PubMed ID: 3807961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure.
    Andress DL; Ott SM; Maloney NA; Sherrard DJ
    N Engl J Med; 1985 Feb; 312(8):468-73. PubMed ID: 3969109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High deposition rate of aluminum in tissues in diabetic hemodialysis patients].
    Iwasaki S; Ideura T; Yoshimura A; Chimata M; Kawamura M; Sudo M; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):723-8. PubMed ID: 2214320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC; LeGendre GR; Kaehny WD
    N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
    Faugere MC; Arnala IO; Ritz E; Malluche HH
    J Lab Clin Med; 1986 Jun; 107(6):481-7. PubMed ID: 3486929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycosylation end products in patients with diabetic nephropathy.
    Makita Z; Radoff S; Rayfield EJ; Yang Z; Skolnik E; Delaney V; Friedman EA; Cerami A; Vlassara H
    N Engl J Med; 1991 Sep; 325(12):836-42. PubMed ID: 1875967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone aluminum uptake in uremic rats receiving intraperitoneal iron.
    Fernández-Martín JL; Fernández-Soto I; Acuña G; Cannata-Andía JB
    Biol Trace Elem Res; 2001; 84(1-3):129-37. PubMed ID: 11817684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
    Parisien M; Charhon SA; Arlot M; Mainetti E; Chavassieux P; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB; Foley J; Nelson P; Goodman WG
    N Engl J Med; 1991 Feb; 324(8):527-31. PubMed ID: 1992306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
    Charhon SA; Chavassieux PM; Chapuy MC; Boivin GY; Meunier PJ
    J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic changes in diabetic uremic patients on hemodialysis.
    Avram MM; Lipner HI; Sadiqali R; Iancu M; Gan AC
    Trans Am Soc Artif Intern Organs; 1976; 22():412-9. PubMed ID: 951859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
    Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
    N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone abnormalities in diabetic hemodialysis patients].
    Okuno S; Inaba M
    Clin Calcium; 2006 Aug; 16(8):1344-50. PubMed ID: 16883043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
    Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; van Hooff I; Dratwa M; Verbeelen D
    Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent and progressing accumulation of aluminum in bone without definite histological osteomalacic aspects in chronic hemodialysis patients.
    Suzuki M; Hirasawa Y; Tanizawa T
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S51-5. PubMed ID: 8608664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
    McCarthy JT; Milliner DS; Johnson WJ
    Q J Med; 1990 Mar; 74(275):257-76. PubMed ID: 2117295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aluminum poisoning].
    Cervar M; Stavljenic A; Vukicević S
    Lijec Vjesn; 1989; 111(4-5):164-9. PubMed ID: 2671563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.